Cargando…
Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours
BACKGROUND: In a clinical diagnostic laboratory, we evaluated the applicability of the Ion Proton sequencer for screening 409 cancer-related genes in solid tumours. METHODS: DNA was extracted from formalin-fixed, paraffin-embedded (FFPE) tissue biopsy specimens of 55 solid tumours (20 with matched n...
Autores principales: | Singh, R R, Patel, K P, Routbort, M J, Aldape, K, Lu, X, Manekia, J, Abraham, R, Reddy, N G, Barkoh, B A, Veliyathu, J, Medeiros, L J, Luthra, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229640/ https://www.ncbi.nlm.nih.gov/pubmed/25314059 http://dx.doi.org/10.1038/bjc.2014.518 |
Ejemplares similares
-
Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory
por: Mehrotra, Meenakshi, et al.
Publicado: (2017) -
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray
por: Chen, Hui, et al.
Publicado: (2017) -
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays
por: Oldridge, Derek A., et al.
Publicado: (2010) -
Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients
por: Wong, S Q, et al.
Publicado: (2015) -
Survey of the transcriptome of Aspergillus oryzae via massively parallel mRNA sequencing
por: Wang, Bin, et al.
Publicado: (2010)